Results of the LMM analysis for GMS change. حسب Sayaka Kimura-Uchida (22793666)

"…The mean GMS was 2.46 ± 1.33 preoperatively, and decreased to 1.32 ± 1.31 at 3 months, and 1.60 ± 1.41 at 12 months postoperatively. …"

Fig 5 - حسب Wardah K. Mustahsan (17484456)

Quality of life and Beck Depression Inventory baseline and post CRT+MRT, CRT and RUHB. حسب Sergio R. Thomaz (20308465)

الموضوعات:

Cardiorespiratory variable measurement of the study population. حسب Sergio R. Thomaz (20308465)

الموضوعات:

Description of the myofascial release techniques. حسب Sergio R. Thomaz (20308465)

الموضوعات:

ΔQuality of life and ΔBeck Depression Inventory baseline and post CRT+MRT, CRT and RUHB. حسب Sergio R. Thomaz (20308465)

الموضوعات:

Study flow diagram. حسب Sergio R. Thomaz (20308465)

الموضوعات:

Changes in maximal strength within each group after treatment. حسب Sergio R. Thomaz (20308465)

الموضوعات:

ΔVO₂ (ml/min), ΔVO₂/HR and ΔVE/VCO₂ slope baseline and post CRT+MRT, CRT and RUHB. حسب Sergio R. Thomaz (20308465)

الموضوعات:

Clinical characteristics of the study population. حسب Sergio R. Thomaz (20308465)

الموضوعات:

Fig 1 - حسب Farshid Maleki (20521649)

Fig 5 - حسب Farshid Maleki (20521649)

Rate of apoptosis in MDA-MB-231 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). حسب Farshid Maleki (20521649)

Fig 10 - حسب Farshid Maleki (20521649)

Rate of apoptosis in MCF-7 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). حسب Farshid Maleki (20521649)

Fig 4 - حسب Farshid Maleki (20521649)

Fig 9 - حسب Farshid Maleki (20521649)

Fig 6 - حسب Farshid Maleki (20521649)

Fig 7 - حسب Farshid Maleki (20521649)

Fig 8 - حسب Farshid Maleki (20521649)